Global Antibody Drug Conjugate Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18749744

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18749744

Global Antibody Drug Conjugate Databank Market Report

The Antibody Drug Conjugate market was valued at $7,625.3 Million in 2022, and is projected to reach $16,326.9 Million by 2031 growing at a CAGR of 8.88% from 2023 to 2031. Blood Cancer segment is expected to be the highest contributor to this market, with $2,539.5 Million in 2022, and is anticipated to reach $4,905.2 Million by 2031, registering a CAGR of 7.63%. Breast Cancer segment is anticipated to reach $5,283.3 Million by 2031 with the highest CAGR of 9.83%. Blood Cancer and Breast Cancer segments collectively expected to account for about 63.2% share of the Antibody Drug Conjugate market in 2022, with the former constituting around 33.3% share. Breast Cancer and Urothelial Cancer & Bladder Cancer segments are expected to witness significant growth rates at a CAGR of 9.83% and 9.69% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 46.4% in the overall Antibody Drug Conjugate market in 2022, and is anticipated to reach 50.0% by 2031.

1. Global Antibody Drug Conjugate Market, By Application: 1.1. Overview; 1.2. Blood Cancer; 1.2.1 Blood Cancer Market, By Region; 1.2.1.1 North America Blood Cancer Market, By Country; 1.2.1.2 Europe Blood Cancer Market, By Country; 1.2.1.3 Asia-Pacific Blood Cancer Market, By Country; 1.2.1.4 Rest of World Blood Cancer Market, By Country; 1.3. Breast Cancer; 1.3.1 Breast Cancer Market, By Region; 1.3.1.1 North America Breast Cancer Market, By Country; 1.3.1.2 Europe Breast Cancer Market, By Country; 1.3.1.3 Asia-Pacific Breast Cancer Market, By Country; 1.3.1.4 Rest of World Breast Cancer Market, By Country; 1.4. Urothelial Cancer & Bladder Cancer; 1.4.1 Urothelial Cancer & Bladder Cancer Market, By Region; 1.4.1.1 North America Urothelial Cancer & Bladder Cancer Market, By Country; 1.4.1.2 Europe Urothelial Cancer & Bladder Cancer Market, By Country; 1.4.1.3 Asia-Pacific Urothelial Cancer & Bladder Cancer Market, By Country; 1.4.1.4 Rest of World Urothelial Cancer & Bladder Cancer Market, By Country; 1.5. Other Cancers; 1.5.1 Other Cancers Market, By Region; 1.5.1.1 North America Other Cancers Market, By Country; 1.5.1.2 Europe Other Cancers Market, By Country; 1.5.1.3 Asia-Pacific Other Cancers Market, By Country; 1.5.1.4 Rest of World Other Cancers Market, By Country
2. Global Antibody Drug Conjugate Market, By Technology: 2.1. Overview; 2.2. Cleavable Linker; 2.2.1 Cleavable Linker Market, By Region; 2.2.1.1 North America Cleavable Linker Market, By Country; 2.2.1.2 Europe Cleavable Linker Market, By Country; 2.2.1.3 Asia-Pacific Cleavable Linker Market, By Country; 2.2.1.4 Rest of World Cleavable Linker Market, By Country; 2.3. Non-Cleavable Linker; 2.3.1 Non-Cleavable Linker Market, By Region; 2.3.1.1 North America Non-Cleavable Linker Market, By Country; 2.3.1.2 Europe Non-Cleavable Linker Market, By Country; 2.3.1.3 Asia-Pacific Non-Cleavable Linker Market, By Country; 2.3.1.4 Rest of World Non-Cleavable Linker Market, By Country; 2.4. Linkerless; 2.4.1 Linkerless Market, By Region; 2.4.1.1 North America Linkerless Market, By Country; 2.4.1.2 Europe Linkerless Market, By Country; 2.4.1.3 Asia-Pacific Linkerless Market, By Country; 2.4.1.4 Rest of World Linkerless Market, By Country
3. Global Antibody Drug Conjugate Market, By Region: 3.1. Overview; 3.2. North America; 3.2.1 North America Antibody Drug Conjugate Market, By Application; 3.2.2 North America Antibody Drug Conjugate Market, By Technology; 3.2.3 North America Antibody Drug Conjugate Market, By Country; 3.2.3.1 U.S.; 3.2.3.1.1 U.S. Antibody Drug Conjugate Market, By Application; 3.2.3.1.2 U.S. Antibody Drug Conjugate Market, By Technology; 3.2.3.2 Canada; 3.2.3.2.1 Canada Antibody Drug Conjugate Market, By Application; 3.2.3.2.2 Canada Antibody Drug Conjugate Market, By Technology; 3.3. Europe; 3.3.1 Europe Antibody Drug Conjugate Market, By Application; 3.3.2 Europe Antibody Drug Conjugate Market, By Technology; 3.3.3 Europe Antibody Drug Conjugate Market, By Country; 3.3.3.1 Germany; 3.3.3.1.1 Germany Antibody Drug Conjugate Market, By Application; 3.3.3.1.2 Germany Antibody Drug Conjugate Market, By Technology; 3.3.3.2 U.K.; 3.3.3.2.1 U.K. Antibody Drug Conjugate Market, By Application; 3.3.3.2.2 U.K. Antibody Drug Conjugate Market, By Technology; 3.3.3.3 France; 3.3.3.3.1 France Antibody Drug Conjugate Market, By Application; 3.3.3.3.2 France Antibody Drug Conjugate Market, By Technology; 3.3.3.4 Italy; 3.3.3.4.1 Italy Antibody Drug Conjugate Market, By Application; 3.3.3.4.2 Italy Antibody Drug Conjugate Market, By Technology; 3.3.3.5 Spain; 3.3.3.5.1 Spain Antibody Drug Conjugate Market, By Application; 3.3.3.5.2 Spain Antibody Drug Conjugate Market, By Technology; 3.3.3.6 Rest of Europe; 3.3.3.6.1 Rest of Europe Antibody Drug Conjugate Market, By Application; 3.3.3.6.2 Rest of Europe Antibody Drug Conjugate Market, By Technology; 3.4. Asia-Pacific; 3.4.1 Asia-Pacific Antibody Drug Conjugate Market, By Application; 3.4.2 Asia-Pacific Antibody Drug Conjugate Market, By Technology; 3.4.3 Asia-Pacific Antibody Drug Conjugate Market, By Country; 3.4.3.1 China; 3.4.3.1.1 China Antibody Drug Conjugate Market, By Application; 3.4.3.1.2 China Antibody Drug Conjugate Market, By Technology; 3.4.3.2 Japan; 3.4.3.2.1 Japan Antibody Drug Conjugate Market, By Application; 3.4.3.2.2 Japan Antibody Drug Conjugate Market, By Technology; 3.4.3.3 South Korea; 3.4.3.3.1 South Korea Antibody Drug Conjugate Market, By Application; 3.4.3.3.2 South Korea Antibody Drug Conjugate Market, By Technology; 3.4.3.4 India; 3.4.3.4.1 India Antibody Drug Conjugate Market, By Application; 3.4.3.4.2 India Antibody Drug Conjugate Market, By Technology; 3.4.3.5 Singapore; 3.4.3.5.1 Singapore Antibody Drug Conjugate Market, By Application; 3.4.3.5.2 Singapore Antibody Drug Conjugate Market, By Technology; 3.4.3.6 Rest of Asia; 3.4.3.6.1 Rest of Asia Antibody Drug Conjugate Market, By Application; 3.4.3.6.2 Rest of Asia Antibody Drug Conjugate Market, By Technology; 3.5. Rest of World; 3.5.1 Rest of World Antibody Drug Conjugate Market, By Application; 3.5.2 Rest of World Antibody Drug Conjugate Market, By Technology; 3.5.3 Rest of World Antibody Drug Conjugate Market, By Country; 3.5.3.1 Brazil; 3.5.3.1.1 Brazil Antibody Drug Conjugate Market, By Application; 3.5.3.1.2 Brazil Antibody Drug Conjugate Market, By Technology; 3.5.3.2 Mexico; 3.5.3.2.1 Mexico Antibody Drug Conjugate Market, By Application; 3.5.3.2.2 Mexico Antibody Drug Conjugate Market, By Technology; 3.5.3.3 South Africa; 3.5.3.3.1 South Africa Antibody Drug Conjugate Market, By Application; 3.5.3.3.2 South Africa Antibody Drug Conjugate Market, By Technology; 3.5.3.4 Australia; 3.5.3.4.1 Australia Antibody Drug Conjugate Market, By Application; 3.5.3.4.2 Australia Antibody Drug Conjugate Market, By Technology; 3.5.3.5 ROW Countries; 3.5.3.5.1 ROW Countries Antibody Drug Conjugate Market, By Application; 3.5.3.5.2 ROW Countries Antibody Drug Conjugate Market, By Technology; ROW Countries Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 2. Blood Cancer Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Blood Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Blood Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Blood Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Blood Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 7. Breast Cancer Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Breast Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Breast Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Breast Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Breast Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 12. Urothelial Cancer & Bladder Cancer Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Urothelial Cancer & Bladder Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Urothelial Cancer & Bladder Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Urothelial Cancer & Bladder Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Urothelial Cancer & Bladder Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 17. Other Cancers Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Other Cancers Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Other Cancers Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Other Cancers Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Other Cancers Market Value, By Country, 2022-2031, Million USD; TABLE 22. Global Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 23. Cleavable Linker Market Value, By Region, 2022-2031, Million USD; TABLE 24. North America Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 25. Europe Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 26. Asia-Pacific Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 27. Rest of World Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 28. Non-Cleavable Linker Market Value, By Region, 2022-2031, Million USD; TABLE 29. North America Non-Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 30. Europe Non-Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 31. Asia-Pacific Non-Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 32. Rest of World Non-Cleavable Linker Market Value, By Country, 2022-2031, Million USD; TABLE 33. Linkerless Market Value, By Region, 2022-2031, Million USD; TABLE 34. North America Linkerless Market Value, By Country, 2022-2031, Million USD; TABLE 35. Europe Linkerless Market Value, By Country, 2022-2031, Million USD; TABLE 36. Asia-Pacific Linkerless Market Value, By Country, 2022-2031, Million USD; TABLE 37. Rest of World Linkerless Market Value, By Country, 2022-2031, Million USD; TABLE 38. Global Antibody Drug Conjugate Market Value, By Region, 2022-2031, Million USD; TABLE 39. North America Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 40. North America Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 41. North America Antibody Drug Conjugate Market Value, By Country, 2022-2031, Million USD; TABLE 42. U.S. Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 43. U.S. Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 44. Canada Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 45. Canada Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 46. Europe Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 47. Europe Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 48. Europe Antibody Drug Conjugate Market Value, By Country, 2022-2031, Million USD; TABLE 49. Germany Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 50. Germany Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 51. U.K. Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 52. U.K. Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 53. France Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 54. France Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 55. Italy Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 56. Italy Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 57. Spain Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 58. Spain Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 59. Rest of Europe Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 60. Rest of Europe Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 61. Asia-Pacific Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 62. Asia-Pacific Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 63. Asia-Pacific Antibody Drug Conjugate Market Value, By Country, 2022-2031, Million USD; TABLE 64. China Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 65. China Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 66. Japan Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 67. Japan Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 68. South Korea Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 69. South Korea Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 70. India Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 71. India Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 72. Singapore Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 73. Singapore Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 74. Rest of Asia Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 75. Rest of Asia Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 76. Rest of World Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 77. Rest of World Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 78. Rest of World Antibody Drug Conjugate Market Value, By Country, 2022-2031, Million USD; TABLE 79. Brazil Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 80. Brazil Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 81. Mexico Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 82. Mexico Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 83. South Africa Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 84. South Africa Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 85. Australia Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 86. Australia Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; TABLE 87. ROW Countries Antibody Drug Conjugate Market Value, By Application, 2022-2031, Million USD; TABLE 88. ROW Countries Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD; ROW Countries Antibody Drug Conjugate Market Value, By Technology, 2022-2031, Million USD